Monika Ashok Davare

Oregon Health and Science University, Portland, OR 
Developmental Neurobiology, Kinases, neurodegeneration
"Monika Davare"
Mean distance: 15.3 (cluster 11)


Sign in to add mentor
Johannes W. Hell grad student 1996-2000 UW Madison
 (Phosphorylation of class C L-type calcium channels: Assembly of a macromolecular signaling complex including beta(2)-adrenergic receptor, protein kinase A and protein phosphatase 2A.)
Thomas Soderling post-doc 2000-2007 OHSU


Sign in to add collaborator
John P. Adelman collaborator OHSU
Gary Banker collaborator OHSU
Soren Impey collaborator OHSU
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Drilon A, Jenkins C, Iyer S, et al. (2020) ROS1-dependent cancers - biology, diagnostics and therapeutics. Nature Reviews. Clinical Oncology
Joshi SK, Qian K, Bisson WH, et al. (2020) Discovery and Characterization of Targetable NTRK Point Mutations in Hematologic Neoplasms. Blood
Jain P, Surrey LF, Straka J, et al. (2020) Abstract A37: Unique gene fusions inform targeted therapeutic strategies across extremely rare, non-CNS pediatric solid tumors Cancer Research. 80
Joshi SK, Bisson W, Qian K, et al. (2019) Discovery & Characterization of Therapeutically Targetable Ntrk Point Mutations in Leukemia Blood. 134: 1256-1256
Davis LE, Nusser KD, Przybyl J, et al. (2018) Discovery and characterization of recurrent, targetable ALK fusions in leiomyosarcoma. Molecular Cancer Research : McR
Tognon CE, Rafn B, Cetinbas NM, et al. (2018) Insulin-like growth factor 1 receptor stabilizes the ETV6-NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradation. The Journal of Biological Chemistry
Hosseini MM, Kurtz SE, Abdelhamed S, et al. (2018) Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes. Leukemia
Joshi SK, Qian K, Wagner JP, et al. (2018) Abstract 970: Transforming NTRK2 and NTRK3 mutations as potential drivers of leukemia Cancer Research. 78: 970-970
Henderson JJ, Wagner JP, Hofmann NE, et al. (2017) Functional validation of the oncogenic cooperativity and targeting potential of tuberous sclerosis mutation in medulloblastoma using a MYC-amplified model cell line. Pediatric Blood & Cancer
Davare MA, Vellore NA, Wagner JP, et al. (2015) Structural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitors. Proceedings of the National Academy of Sciences of the United States of America
See more...